10-Q: Premier Inc. Reports Q2 Fiscal Year 2025 Results, Including Goodwill Impairment Charge

Premier Inc. reports a net loss for Q2 2025, impacted by a goodwill impairment charge and decreased revenue in both Supply Chain and Performance Services segments.

Summary

• Premier Inc. reported a net loss of $85.2 million for the second quarter of fiscal year 2025, compared to a net income of $52.9 million for the same period last year.
• Net revenue decreased by 14% to $240.3 million, with declines in both Supply Chain Services and Performance Services segments.
• The company recorded a goodwill impairment charge of $126.8 million related to the Informatics and Technology Services (ITS) reporting unit.
• Adjusted EBITDA decreased by 48% to $50.1 million.
• The Supply Chain Services segment experienced a revenue decrease due to higher fee share paid to members.
• The Performance Services segment saw a revenue decline due to lower demand for consulting services and SaaS-based products.
• The company completed $200 million of share repurchases under its share repurchase authorization.
• A quarterly cash dividend of $0.21 per share was declared, payable on March 15, 2025.

Sentiment

Score: 3

Explanation: The document presents a negative outlook due to the reported net loss, revenue decline, and goodwill impairment charge. While the company is taking steps to return capital to shareholders, the overall tone is pessimistic.

Positives

• The company completed $200 million of share repurchases, returning capital to shareholders.
• A quarterly cash dividend of $0.21 per share was declared, providing income to shareholders.
• The company continues to expand its capabilities to more fully address and coordinate care improvement and standardization in the employer, payer, and life sciences markets.

Negatives

• The company reported a net loss of $85.2 million, a significant decline from the prior year.
• Net revenue decreased by 14%, indicating challenges in both Supply Chain and Performance Services segments.
• The goodwill impairment charge of $126.8 million significantly impacted the company's financial results.
• Adjusted EBITDA decreased by 48%, reflecting lower profitability.
• The Supply Chain Services segment experienced a revenue decrease due to higher fee share paid to members.
• The Performance Services segment saw a revenue decline due to lower demand for consulting services and SaaS-based products.

Risks

• Competition could limit the ability to maintain or expand market share.
• Reliance on administrative fees from suppliers and the ability to maintain and add new GPO members.
• Consolidation in the healthcare industry.
• Potential delays in recognizing or increasing revenue if the sales cycle or implementation period takes longer than expected.
• The impact to the business if members of GPO programs reduce activity levels or terminate or elect not to renew their contracts.
• The rate at which the markets for SaaS or licensed-based clinical analytics products and services develop.
• Dependency of members on payments from third-party payers.
• Ability to timely offer new and innovative products and services, including the integration of artificial intelligence.
• Reliance on Internet infrastructure, bandwidth providers, data center providers and other third parties, and our own systems for providing services to our users.
• Data loss or corruption due to failures or errors in our systems and service disruptions at our data centers, or breaches or failures of our security measures.
• The financial, operational, legal, and reputational consequences of cyber-attacks or other data security breaches.
• Our ability to use, disclose, de-identify, or license data and to integrate third-party technologies.
• Our dependency on contract manufacturing facilities located in various parts of the world.
• Inventory risk we face in the event of a potential material decline in demand or price for the personal protective equipment or other products we may have purchased at elevated market prices or fixed prices.
• Our ability to attract, hire, integrate, and retain key personnel.
• The impact of continuing uncertain economic conditions on our business operations due to, but not limited to, inflation and recessionary fears.
• The financial and operational uncertainty due to global macroeconomic, geopolitical, and business conditions, trends and events, and the impact of any associated supply chain challenges.
• The impact of global climate change or by regulatory responses to such change.
• Changes and uncertainty in the political, economic, or regulatory environment affecting healthcare organizations, including with respect to the status of the Patient Protection and Affordable Care Act, as amended by the Healthcare and Education Reconciliation Act of 2010.
• Our compliance with complex international, federal, and state laws, rules and regulations governing financial relationships among healthcare providers, and the submission of false or fraudulent healthcare claims.
• Interpretation and enforcement of current or future antitrust laws and regulations.
• Compliance with complex federal, state, and international privacy, security, and breach notification laws.
• Compliance with current or future laws, rules, and regulations relating to information blocking provisions of the 21st Century Cures Act issued by the Office of the National Coordinator for Health Information Technology (the ONC Rules) that may cause our certified Health Information Technology products to be regulated by the ONC Rules.
• Compliance with current or future laws, rules, and regulations adopted by the Food and Drug Administration applicable to our software applications that may be considered medical devices.
• The impact on our business of Executive Orders issued by the President of the United States.
• Adequate protection of our intellectual property and potential claims against our use of the intellectual property of third parties.
• Potential for additional indirect tax liabilities, such as gross receipts and sales and use taxes, in certain jurisdictions.
• Changes in tax laws that materially impact our tax rate, income tax expense, anticipated tax benefits, deferred tax assets, cash flows, and profitability and potential material tax disputes.
• The impact of payments required under notes payable to former limited partners related to the early termination of the Unit Exchange and Tax Receivable Acceleration Agreements (the Unit Exchange Agreements) issued in connection with our August 2020 Restructuring on our overall cash flow and our ability to fully realize the expected tax benefits to match such fixed payment obligations under those notes payable.
• Provisions in our certificate of incorporation and bylaws and provisions of Delaware law and other applicable laws that discourage or prevent strategic transactions, including a takeover of us.
• The impact of stockholder activism, takeover proposals, proxy contests, or short sellers.
• Our indebtedness and our ability to obtain additional financing on favorable terms, including our ability to renew or replace our long-term credit facility at or before maturity.
• Fluctuation of our quarterly cash flows, revenues, and results of operations.
• Failure to maintain an effective system of internal controls over financial reporting or an inability to remediate any weaknesses identified and the related costs of remediation.
• The impact on the price of our Class A common stock (Common Stock) if we cease paying dividends or reduce dividend payments from current levels.
• The number of shares of our Common Stock repurchased by us pursuant to any then-existing Common Stock repurchase program and the timing of any such repurchases.
• The number of shares of Common Stock eligible for sale after the issuance of Common Stock in our August 2020 Restructuring and the potential impact of such sales.
• The risk factors discussed under the heading Risk Factors under Item 1A of our Annual Report on Form 10-K for the fiscal year ended June 30, 2024 (the 2024 Annual Report) filed with the Securities and Exchange Commission (SEC), as updated by our Quarterly Reports on Form 10-Q (including this Quarterly Report) filed with the SEC.

Future Outlook

The company expects certain trends and economic or industry-wide factors will continue to affect the business in both the shortand long-term, including the impact of inflation, rising labor costs, and healthcare legislation.

Management Comments

• The document does not contain any direct quotes from management.

Industry Context

The announcement reflects the challenges faced by healthcare companies in a dynamic environment, including cost pressures, changing market dynamics, and the need for strategic realignments.

Comparison to Industry Standards

• The document does not contain any specific comparisons to industry standards.
• Without specific comparables, it's difficult to assess Premier's performance against industry benchmarks.
• A deeper dive into the performance of companies like Vizient, Medline, or other GPOs would provide a better context.

Management Changes

Corporate Governance

Legal Proceedings

• The Company is periodically involved in litigation, arising in the ordinary course of business or otherwise, which from time to time may include stockholder derivative or other similar litigation, claims relating to commercial, product liability, tort and personal injury, employment, antitrust, intellectual property, or other regulatory matters.
• From time to time we have been named as a defendant in class action antitrust lawsuits brought by suppliers or purchasers of medical products.

Stakeholder Impact

• Shareholders: Impacted by net loss, but also benefit from share repurchases and dividends.
• Employees: Potential impact from cost-cutting measures or strategic shifts.
• Customers: May experience changes in service offerings or pricing.
• Suppliers: Potential impact from changes in GPO contracts or relationships.

Next Steps

• The company will continue to monitor the impacts of geopolitical tensions on macroeconomic conditions and prepare for any implications they may have on member demand, suppliers' ability to deliver products, cybersecurity risks, and liquidity and access to capital.
• The company expects quarterly dividends to continue to be paid on or about December 15, March 15, June 15, and September 15, respectively.
• The company will continue to address member agreements for renewal representing a cumulative total of greater than 75% of the gross administrative fees associated with the member agreements extended in 2020.

Key Dates

Keywords

financial results, goodwill impairment, revenue decline, share repurchase, dividend, supply chain services, performance services, net loss, adjusted EBITDA, GPO, healthcare, Premier Inc.